10h
Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder
Dosing initiates clinical evaluation of NPX-5, a GMP-compliant, nature-derived psilocybin candidate across an expanded Australian site networkNEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Psyence ...
Stratford wasn’t the only local site for Chinese laundries. Searching through historical newspapers using the Stratford-Perth ...
LISTOWEL - What the mayor is calling the largest capital project of his time, received approval for a second phase from council on April 13.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results